Arterex Acquires Adroit USA Inc.

Aptyx Acquires Argos Corporation to Launch Precision Extrusion Center of Excellence

December 5, 2025

Medical Devices

Aptyx has acquired Argos Corporation, a Massachusetts-based precision extrusion specialist, and will establish a Boston-area Precision Extrusion Center of Excellence to expand medical tubing and catheter-grade extrusion capacity. The deal enhances Aptyx’s capabilities for interventional and catheter-based device markets, adding in-house tooling and micro-extrusion expertise to its integrated medical manufacturing platform.

Arterex (Investindustrial-backed) Acquires NextPhase Medical Devices

July 17, 2023

Medical Devices

Arterex (Medical Device, Inc.), an Investindustrial-backed medical device contract manufacturer, has acquired NextPhase Medical Devices from Kidd & Company, LLC. The deal expands Arterex’s global multi-capability platform — nearly doubling the group’s scale and adding complementary design, engineering and complex electromechanical and implantable device manufacturing capabilities across North America and internationally.

Argon Medical Devices Acquires Matrex Mold and Tool

December 14, 2021

Medical Devices

Argon Medical Devices, a U.S.-based medical device manufacturer, acquired Matrex Mold and Tool, a Portage, Wisconsin custom mold and tool manufacturer. The acquisition vertically integrates Argon's manufacturing capabilities, enabling in-house production of prototype and production molds to improve quality control and shorten time-to-market.

Aptyx Acquires Medical Murray's Charlotte, North Carolina Facility

January 21, 2025

Medical Devices

Aptyx, a TruArc-backed medical device manufacturing platform, has acquired the Charlotte, North Carolina facility of Medical Murray to expand its interventional and implantable product capabilities. The acquisition brings engineering talent and ISO Class 7 manufacturing capacity for catheter-based interventional products, transcatheter implants and biotextiles into Aptyx Interventional Systems.

Integra LifeSciences Acquires Acclarent, Inc.

April 1, 2024

Medical Devices

Integra LifeSciences Holdings Corporation has completed its acquisition of Acclarent, Inc., a maker of ear, nose and throat (ENT) surgical devices. The transaction expands Integra’s product portfolio into the ENT device segment, adding approximately $1 billion to the company’s total addressable market and providing scale through Acclarent’s commercial and R&D capabilities.

LeMaitre Vascular Acquires Artegraft

June 22, 2020

Medical Devices

LeMaitre Vascular, Inc. acquired the business and assets of Artegraft, Inc. for $90.0 million (including $72.5 million at closing and up to $17.5 million in earnouts). The acquisition adds Artegraft's biologic vascular graft product line (used primarily for hemodialysis access) to LeMaitre's portfolio and will keep Artegraft's North Brunswick, New Jersey manufacturing facility and most employees in place.